VITA Group have been hurt by rumours of a Telstra buy back of its high performing stores which sent its share price sharply downwards.
ERM Power took a 226 per cent hit to its profits although it has forecast a return to solid margins.
And both Impedimed and Capilano Honey have been spending money on research and development, with the end game for each likely to see a turnaround in their performances.
|
|
CLICK BELOW FOR THIS YEAR'S TOP 50
Click here to return to the 2017 Top Companies home page
Get our daily business news
Sign up to our free email news updates.
Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support